Physician profile
David B Warren
NPI 1043272651
$11,202.30
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $128 · 2021: $8,459 · 2022: $194 · 2023: $270 · 2024: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,664.24 | 2019-2022 | |
| Abbvie INC. | $390.19 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $216.04 | 2019-2024 | Veozah, Myrbetriq |
| Nevro Corp. | $135.26 | 2019 | |
| Organon LLC | $108.85 | 2023-2024 | Nexplanon |
| Pfizer INC. | $104.24 | 2021-2024 | |
| Therapeuticsmd, INC. | $83.69 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $69.49 | 2023-2024 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Mayne Pharma Commercial LLC | $64.69 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.68 | 2019-2024 | |
| Duchesnay USA Incorporated | $49.51 | 2019 | |
| Novo Nordisk INC | $43.13 | 2023-2024 | Wegovy |
| Amgen INC. | $39.99 | 2019 | |
| Allergan, INC. | $32.12 | 2020 | |
| Daiichi Sankyo INC. | $31.51 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $26.43 | 2019-2020 | |
| Davol INC. | $22.81 | 2022 | |
| Biogen, INC. | $21.07 | 2024 | |
| Lilly USA, LLC | $17.95 | 2024 | Zepbound |
| Scynexis, INC. | $15.64 | 2022 | |
| Baxter Healthcare | $13.77 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.